ijms-logo

Journal Browser

Journal Browser

Inflammatory Bowel Disease: From Genetics to Treatment

A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Genetics and Genomics".

Deadline for manuscript submissions: 28 February 2025 | Viewed by 105

Special Issue Editor


E-Mail Website
Guest Editor
Inflammatory Bowel Disease Institute, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA
Interests: Crohn's disease; inflammatory bowel diseases; ulcerative colitis

Special Issue Information

Dear Colleagues,

Inflammatory Bowel Disease (IBD) encompasses chronic inflammatory conditions of the gastrointestinal tract, including Crohn's disease and ulcerative colitis. These diseases are characterized by a complex interplay of genetic, environmental, microbial, and immune factors, leading to chronic inflammation of the gut. The relationship between genetic predisposition and the development of Inflammatory Bowel Disease (IBD), including its two main forms, Crohn's disease and ulcerative colitis. IBD is characterized by chronic inflammation of the gastrointestinal tract, and its etiology involves a complex interplay between genetic and environmental factors. Recent advancements in genome-wide association studies (GWAS) have identified numerous genetic loci associated with IBD, shedding light on the genetic predisposition to the disease. These studies have enhanced our understanding of the genetic architecture of IBD, revealing insights into the underlying biological pathways that contribute to disease susceptibility and progression. Identifying these genetic factors is crucial for developing targeted therapies and personalized medicine approaches for IBD patients. The latest research on genetic predisposition in IBD emphasizes the role of specific genetic variants and their impact on disease phenotypes. It also explores the potential of integrating genetic data with clinical and environmental information to improve disease prediction, diagnosis, and treatment strategies. By examining the genetic basis of IBD, researchers aim to uncover novel therapeutic targets and biomarkers that can lead to more effective and individualized treatment options for patients. Moreover, the issue addresses the therapeutic implications of these genetic findings, discussing current and emerging treatments for IBD. It highlights the role of biologics, small-molecule inhibitors, and other novel therapeutic strategies in managing the disease. The integration of genetic information with therapeutic approaches holds great promise.

Dr. Dalin Li
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • genetic predisposition
  • inflammatory bowel disease
  • genome-wide association study Crohn's disease
  • ulcerative colitis
  • bowel disease

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue polices can be found here.

Published Papers

This special issue is now open for submission.
Back to TopTop